Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain
by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that
Updated on: April 16,2024
14
Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain
by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that
Updated on:April 16,2024
14
